FDA Brief

Company record

VasoCorp, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about VasoCorp, Inc..

Warning letters

  1. VasoCorp, Inc.

    FDA says VasoCorp markets NeuropAWAY supplements as unapproved drugs with disease-treatment claims.

    High risk